Skip to content

Drug interactions

Methylphenidate + Tranylcypromine

Severity: Contraindicated

Methylphenidate and Tranylcypromine: contraindicated interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Methylphenidate given with an MAO inhibitor can cause severe hypertensive reactions as stored catecholamines are released and not degraded. The combination is contraindicated in labeling.

What this interaction means in plain words

Methylphenidate and Tranylcypromine are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Methylphenidate belongs to Central Nervous System; Tranylcypromine belongs to Central Nervous System.

Evidence level: High

Why it happens

Methylphenidate increases synaptic norepinephrine and dopamine while MAO inhibition prevents their metabolism, causing pressor excess.

What to do

Do not co-administer, and wait at least 14 days after stopping tranylcypromine before starting methylphenidate. Consider non-stimulant options.

What to ask your pharmacist

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Methylphenidate and Tranylcypromine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Methylphenidate with Tranylcypromine?

MediHelp rates the interaction as contraindicated. Methylphenidate and Tranylcypromine are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Methylphenidate given with an MAO inhibitor can cause severe hypertensive reactions as stored catecholamines are released and not degraded. The combination is contraindicated in labeling.

How serious is the interaction between Methylphenidate and Tranylcypromine?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Do not co-administer, and wait at least 14 days after stopping tranylcypromine before starting methylphenidate. Consider non-stimulant options.

What other medicines interact with Tranylcypromine?

MediHelp also lists interactions of Tranylcypromine with, for example, 5-HTP, Amitriptyline, Amoxapine. The full list is on the Tranylcypromine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in